These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 2981619
1. Combined intravenous and intra-arterial cyclophosphamide, doxorubicin, and cisplatin (CISCA) in the management of select patients with invasive urothelial tumors. Logothetis CJ, Samuels ML, Selig DE, Wallace S, Johnson DE. Cancer Treat Rep; 1985 Jan; 69(1):33-8. PubMed ID: 2981619 [Abstract] [Full Text] [Related]
2. Cyclophosphamide, doxorubicin and cisplatin chemotherapy for patients with locally advanced urothelial tumors with or without nodal metastases. Logothetis CJ, Samuels ML, Ogden S, Dexeus FH, Swanson D, Johnson DE, von Eschenbach A. J Urol; 1985 Sep; 134(3):460-4. PubMed ID: 2993671 [Abstract] [Full Text] [Related]
3. Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer--phase I/II study. Yoshida O, Kakehi Y, Arai Y, Tomoyoshi T, Okada Y, Matsuda T, Mikami O, Fukuyama T, Hida S, Okabe T. Int J Urol; 1995 Nov; 2(5):316-21. PubMed ID: 8749950 [Abstract] [Full Text] [Related]
4. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report. Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T. Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990 [Abstract] [Full Text] [Related]
5. [Clinical and pathological evaluations of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) chemotherapy for advanced urothelial cancers]. Takenaka A, Gotoh A, Hara I, Gohji K, Ogawa T, Arakawa S, Matsumoto O, Kamidono S, Hamami G, Itani A. Gan To Kagaku Ryoho; 1990 Sep; 17(9):1909-15. PubMed ID: 2393308 [Abstract] [Full Text] [Related]
9. Preoperative and postoperative adjuvant chemotherapy using CISCA (cyclophosphamide, doxorubicin, and cisplatin) in the treatment of invasive transitional-cell carcinoma of the bladder. Lynch DF. Urol Clin North Am; 1991 Aug; 18(3):543-6. PubMed ID: 1877118 [Abstract] [Full Text] [Related]
10. [Intra-arterial chemotherapy of patients in the late stages of bladder cancer]. Dunchik VN, Drozdovskiĭ BIa, Kariakin OB, Grishin GN. Urol Nefrol (Mosk); 1985 Aug; (2):19-23. PubMed ID: 3992752 [No Abstract] [Full Text] [Related]
14. [Arterial infusion chemotherapy for patients with advanced and moderately advanced cancer of urinary bladder]. Li Q, Xu X, Liu J. Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):308-9. PubMed ID: 10920993 [Abstract] [Full Text] [Related]
15. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy. George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N. Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577 [Abstract] [Full Text] [Related]
16. Therapeutic experience of advanced urothelial tract tumors. Nakada T, Akiya T, Yoshikawa M, Umeda K, Katayama T. Hinyokika Kiyo; 1985 Apr; 31(4):601-6. PubMed ID: 4041118 [Abstract] [Full Text] [Related]